Our hospital blood bank just purchased a new cesium blood irradiator 2 years ago
at the cost of $198,900 plus the newly required import/export licensing fees of
$6,000. We looked at x-ray irradiators at that time. These could not handle our
volume, so we would have had to purchase 2 x-ray devices. The x-ray tubes were
unpredictable, we would have had to maintain an inventory of tubes, adding to the
costs. We also did not have sufficient space for 2 x-ray irradiators. It was an
easy decision to remain with the cesium-sourced irradiator. If the NRC
incorporates new regulations mandating that all cesium irradiators be replaced,
the
NRC cannot expect hospitals that have just purchased irradiators to absorb those
costs. As long as we have sufficent increased controls in place to assure
security
of the device (as assured by the NRC inspection on site here), existing cesium
irradiators should not be required to be replaced. If immediate replacement is
mandated, time is needed for appropriate budgeting processes, and financial
incentives must offset the loss.
Comment (4) from Ken Love, Christiana Core Health Services, Newark, DE
This is comment on Notice
Request for Comments on the Security and Continued Use of Cesium- 137 Chloride Sources and Notice of Public Meeting
View Comment
Related Comments
View AllPublic Submission Posted: 08/08/2008 ID: NRC-2008-0419-0002
Sep 30,2008 11:59 PM ET
Public Submission Posted: 08/08/2008 ID: NRC-2008-0419-0003
Sep 30,2008 11:59 PM ET
Public Submission Posted: 08/08/2008 ID: NRC-2008-0419-0004
Sep 30,2008 11:59 PM ET
Public Submission Posted: 08/08/2008 ID: NRC-2008-0419-0005
Sep 30,2008 11:59 PM ET
Public Submission Posted: 08/08/2008 ID: NRC-2008-0419-0006
Sep 30,2008 11:59 PM ET